ID6611 Obesity, overweight - semaglutide (including review of TA875)

Status:

Topic prioritisation

Technology type:

Medicine

Decision:

Awaiting decision

Timeline

Key events during the development of the guidance:

For further information on how we select topics for development, please see our page about topic prioritisation